Syngen Biotech Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 1,311.436 million compared to TWD 1,297.269 million a year ago. Operating income was TWD 259.265 million compared to TWD 242.895 million a year ago. Net income was TWD 215.550 million compared to TWD 188.765 million a year ago. Basic earnings per share was TWD 7.95 compared to TWD 7.86 a year ago. Diluted earnings per share was TWD 7.94 compared to TWD 7.85 a year ago.